vs
Side-by-side financial comparison of Delek US Holdings, Inc. (DK) and Organon & Co. (OGN). Click either name above to swap in a different company.
Delek US Holdings, Inc. is the larger business by last-quarter revenue ($2.6B vs $1.5B, roughly 1.7× Organon & Co.). Delek US Holdings, Inc. runs the higher net margin — -7.7% vs -13.6%, a 6.0% gap on every dollar of revenue. On growth, Delek US Holdings, Inc. posted the faster year-over-year revenue change (-4.9% vs -5.3%). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -10.8%).
Delek US Holdings, Inc. is an oil refining, logistics and biofuels company founded in 2001 and headquartered in Brentwood, Tennessee.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
DK vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.6B | $1.5B |
| Net Profit | $-201.3M | $-205.0M |
| Gross Margin | -5.8% | 49.2% |
| Operating Margin | — | -9.8% |
| Net Margin | -7.7% | -13.6% |
| Revenue YoY | -4.9% | -5.3% |
| Net Profit YoY | — | -288.1% |
| EPS (diluted) | $-3.34 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.4B | $1.5B | ||
| Q3 25 | $2.9B | $1.6B | ||
| Q2 25 | $2.8B | $1.6B | ||
| Q1 25 | $2.6B | $1.5B | ||
| Q4 24 | $2.4B | $1.6B | ||
| Q3 24 | $3.0B | $1.6B | ||
| Q2 24 | $3.3B | $1.6B |
| Q1 26 | $-201.3M | — | ||
| Q4 25 | $78.3M | $-205.0M | ||
| Q3 25 | $178.0M | $160.0M | ||
| Q2 25 | $-106.4M | $145.0M | ||
| Q1 25 | $-172.7M | $87.0M | ||
| Q4 24 | $-413.8M | $109.0M | ||
| Q3 24 | $-76.8M | $359.0M | ||
| Q2 24 | $-37.2M | $195.0M |
| Q1 26 | -5.8% | — | ||
| Q4 25 | 9.3% | 49.2% | ||
| Q3 25 | 13.8% | 53.5% | ||
| Q2 25 | 1.9% | 54.8% | ||
| Q1 25 | -2.4% | 55.6% | ||
| Q4 24 | -5.7% | 56.3% | ||
| Q3 24 | -0.7% | 58.3% | ||
| Q2 24 | 0.5% | 58.4% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | -9.8% | ||
| Q3 25 | 10.2% | 15.2% | ||
| Q2 25 | -1.2% | 14.4% | ||
| Q1 25 | -4.8% | 6.7% | ||
| Q4 24 | -17.0% | 8.1% | ||
| Q3 24 | -4.0% | 13.1% | ||
| Q2 24 | 0.1% | 14.6% |
| Q1 26 | -7.7% | — | ||
| Q4 25 | 3.2% | -13.6% | ||
| Q3 25 | 6.2% | 10.0% | ||
| Q2 25 | -3.8% | 9.1% | ||
| Q1 25 | -6.5% | 5.8% | ||
| Q4 24 | -17.4% | 6.8% | ||
| Q3 24 | -2.5% | 22.7% | ||
| Q2 24 | -1.1% | 12.1% |
| Q1 26 | $-3.34 | — | ||
| Q4 25 | $1.23 | $-0.78 | ||
| Q3 25 | $2.93 | $0.61 | ||
| Q2 25 | $-1.76 | $0.56 | ||
| Q1 25 | $-2.78 | $0.33 | ||
| Q4 24 | $-6.48 | $0.42 | ||
| Q3 24 | $-1.20 | $1.38 | ||
| Q2 24 | $-0.58 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $624.1M | $574.0M |
| Total DebtLower is stronger | $3.2B | $8.6B |
| Stockholders' EquityBook value | $302.0M | $752.0M |
| Total Assets | $7.6B | $12.9B |
| Debt / EquityLower = less leverage | 10.54× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $624.1M | — | ||
| Q4 25 | $625.8M | $574.0M | ||
| Q3 25 | $630.9M | $672.0M | ||
| Q2 25 | $615.5M | $599.0M | ||
| Q1 25 | $623.8M | $547.0M | ||
| Q4 24 | $735.6M | $675.0M | ||
| Q3 24 | $1.0B | $763.0M | ||
| Q2 24 | $657.9M | $704.0M |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $8.6B | ||
| Q3 25 | $3.2B | $8.8B | ||
| Q2 25 | $3.1B | $8.9B | ||
| Q1 25 | $3.0B | $9.0B | ||
| Q4 24 | $2.8B | $8.9B | ||
| Q3 24 | $2.8B | $8.7B | ||
| Q2 24 | $2.5B | $8.7B |
| Q1 26 | $302.0M | — | ||
| Q4 25 | $547.3M | $752.0M | ||
| Q3 25 | $444.8M | $906.0M | ||
| Q2 25 | $294.9M | $733.0M | ||
| Q1 25 | $429.4M | $542.0M | ||
| Q4 24 | $575.2M | $472.0M | ||
| Q3 24 | $875.4M | $493.0M | ||
| Q2 24 | $982.8M | $144.0M |
| Q1 26 | $7.6B | — | ||
| Q4 25 | $6.8B | $12.9B | ||
| Q3 25 | $7.1B | $13.6B | ||
| Q2 25 | $7.1B | $13.5B | ||
| Q1 25 | $6.9B | $13.2B | ||
| Q4 24 | $6.7B | $13.1B | ||
| Q3 24 | $7.0B | $12.8B | ||
| Q2 24 | $6.9B | $12.2B |
| Q1 26 | 10.54× | — | ||
| Q4 25 | 5.91× | 11.49× | ||
| Q3 25 | 7.14× | 9.74× | ||
| Q2 25 | 10.51× | 12.14× | ||
| Q1 25 | 7.07× | 16.52× | ||
| Q4 24 | 4.81× | 18.81× | ||
| Q3 24 | 3.19× | 17.75× | ||
| Q2 24 | 2.50× | 60.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $141.0M |
| Free Cash FlowOCF − Capex | — | $96.0M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $502.8M | $141.0M | ||
| Q3 25 | $44.0M | $264.0M | ||
| Q2 25 | $51.4M | $220.0M | ||
| Q1 25 | $-62.4M | $75.0M | ||
| Q4 24 | $-163.5M | $390.0M | ||
| Q3 24 | $-21.6M | $141.0M | ||
| Q2 24 | $-48.4M | $332.0M |
| Q1 26 | — | — | ||
| Q4 25 | $382.8M | $96.0M | ||
| Q3 25 | $-64.0M | $218.0M | ||
| Q2 25 | $-114.4M | $181.0M | ||
| Q1 25 | $-198.1M | $43.0M | ||
| Q4 24 | $-354.0M | $335.0M | ||
| Q3 24 | $-140.6M | $99.0M | ||
| Q2 24 | $-128.3M | $300.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.8% | 6.4% | ||
| Q3 25 | -2.2% | 13.6% | ||
| Q2 25 | -4.1% | 11.4% | ||
| Q1 25 | -7.5% | 2.8% | ||
| Q4 24 | -14.9% | 21.0% | ||
| Q3 24 | -4.6% | 6.3% | ||
| Q2 24 | -3.9% | 18.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 3.0% | ||
| Q3 25 | 3.7% | 2.9% | ||
| Q2 25 | 6.0% | 2.4% | ||
| Q1 25 | 5.1% | 2.1% | ||
| Q4 24 | 8.0% | 3.5% | ||
| Q3 24 | 3.9% | 2.7% | ||
| Q2 24 | 2.4% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 6.42× | — | ||
| Q3 25 | 0.25× | 1.65× | ||
| Q2 25 | — | 1.52× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
